View the NDEWS Weekly Briefing Issue 223 in your browser ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­
webversion | unsubscribe | update profile
 
Issue 223: March 21, 2025
 
new briefing header (1)
 

NDEWS Special Report: EMS encounters in the US for nonfatal tusi-related overdoses

 
 

In this week’s report, NDEWS highlights observations from biospatial.io detailing the EMS encounters in the US for nonfatal tusi-related overdoses from 2022 to 2025. The data shows that all counties with the highest rates of nonfatal tusi-related overdose encounters over 38 months were on the east coast and west coast—especially the southeast and southwest of the US. Among states with at least 75% coverage,* there were 105 nonfatal tusi-related overdose encounters.

To view the entire Special Report from our Weekly Briefing, click here.


Click here to learn more about NDEWS Hotspot Alerts
 
ndews_special_report_ems_encounters_in_the_us_for_nonfatal_tusirelated-overdoses-2
share your thoughts-01
twitter button-01
 

Alert from the NDEWS Web Monitoring Team: Tucibi

 
2025-03-21_sum_of_tusi_pink_cocaine_reddit_posts_unique_users_in_a_rolling_60-day_window
 

What was found? Tucibi had a steady increase from early 2020 to September 2024. There was a sharp increase from September to November, likely due to discussion about the death of Liam Payne that occurred October 16, 2024. This was followed by a sharp drop from November to January and activity has remained steady since then.

Past Reports:
October 11, 2024
July 19, 2024
February 2, 2023

What is Tucibi? Tucibi, also known as "tusi" or "pink cocaine," is a polysubstance concoction that has emerged in recent years. Tucibi and Tusi are the phonetic translations of 2C-B and 2C, respectively, but this concoction rarely contains 2C series drugs.

How is it being discussed? Online discussions about Tucibi often center on its inconsistent effects and ingredients. Reddit users report that Tucibi is a highly variable mixture of various substances, including MDMA, ketamine, caffeine, “bath salts”, fentanyl, and/or other opioids. There is frequent mention of its popularity as a recreational substance, particularly in rave settings. Discussants often warn about the unpredictability of its effects due to variability in what drugs the mixture contains. The risk of inclusion of highly potent and dangerous substances like fentanyl in some Tucibi mixtures is a particular cause for concern in these discussions. There is also a discussion of distrust towards Tucibi due to its purported origin in Central American cartels.

Drug Terms Searched: Tucibi, tusi, tussi, pink cocaine, pink tusi
Click here to read more about NDEWS Online Monitoring.
 
share your thoughts-01
twitter button-01
 

RECENTLY PUBLISHED

 
 

Tusi but not 2C: A Miami-Dade medical examiner case series highlighting the variable drug composition in colored powder paraphernalia 

 
3-21-25_tusi-but-not-2c-2
 

A recently published case report in the Journal of Forensic Sciences by Moore et al. examines eight fatalities in Miami-Dade County associated with the ingestion of “tusi,” also known as “pink cocaine.” The report highlights the variable composition of these colored powders, which were found within ketamine-positive cases, frequently in combination with MDMA, and occasionally with other stimulants (cocaine, methamphetamine, MDA), opioids (oxycodone), benzodiazepines (alprazolam), and synthetic cathinones (eutylone). Notably, none of the powders contained 2C-B, despite the name's phonetic association with the 2C-class of hallucinogens.

Read more here.

Media Coverage
 - 'Pink cocaine' identified in South Florida overdose deaths - USA Today

 
twitter button-01
twitter button-01
 

What is pink cocaine? The dark reality behind a colorful name 

 
3-21-25_what_is_pink_cocain
 

A recently published editorial in the Journal of Medicinal Chemistry by Barbaro and Bouchard explores the growing prevalence of “pink cocaine” (also known as “tusi” or “tucibi”) and its deceptive marketing as a stimulant similar to cocaine. The authors clarify that pink cocaine is not a new drug, but an inconsistent mixture primarily composed of ketamine and MDMA, often laced with additional psychoactive substances, including amphetamines, opioids, and tranquilizers. Analysis of 68 samples submitted to drug-checking programs between 2016 and 2024 found ketamine in 94% of cases and MDMA in 81%, with wide variability in composition and potency.

Read more here.
 
twitter button-01
twitter button-01
 

IN THE NEWS

 
 

DEA finds tusi, or pink cocaine, is starting to appear in Colorado

 
3-21-25_dea-finds-tusi-or-pink-cocaine-is-starting-to-appear-in-colorado
 

A recent news report from KDVR Denver highlights the emergence of "tusi," or pink cocaine, in Colorado, as identified by the U.S. Drug Enforcement Administration Rocky Mountain Division during recent raids. DEA officials note that the drug, which has been circulating in Miami and other U.S. cities, is now appearing "quite a bit" in Colorado’s party and club scene. Given its inconsistent composition and unknown potency, authorities warn of its serious risks, particularly in overdose potential and dangerous drug interactions. Law enforcement is monitoring the drug’s presence and its potential connections to organized crime networks.
Read more here.
 
twitter button-01
twitter button-01
 

Tracking emerging drug trends - Question for the community:

 
2025-03_tusi_use
 

Submit any information concerning the use of tusi in your area here.
Is there any other information NDEWS should know about related to substance use, overdoses (fatal or nonfatal) or other drug-related trends in your area, including trends associated with polysubstance or co-use? Share it via our submission form here!
 
NDEWS_Briefing_Emerging Drugs Form
Request for Information
 

RECENTLY PUBLISHED

 
 

Naloxone acceptance among nightclub attendees in New York City

 
2.21.25 Naloxone_Distribution_NeedsBased_Syringe_Services_Program
 

A recently published study in Journal of Community Health by Abukahok et al., co-authored by NDEWS Co-Director Dr. Palamar, examined naloxone acceptance among nightclub attendees in New York City. Of 991 adults surveyed, 62.1% agreed to receive a naloxone kit, but only 49.6% were recorded as accepting a kit. Higher acceptance was linked to NYC residency (aPR = 1.41), naloxone familiarity (aPR = 1.27), and greater readiness to intervene in overdoses (aPR = 1.18). Misconceptions were common—35.4% mistakenly believed naloxone reverses cocaine or any drug effects.

Read more here.
 
twitter button-01
twitter button-01
 

UPCOMING WEBINARS & EVENTS

 
national-association-of-state-controlled-substances-authorities
 

 Kratom update, from powerful 7-OH and pseudoindoxyl extracts, child marketing, and heavy metals

 
 

📅 Date: Wednesday, April 9, 2025
🕑 Time: 3:00 pm ET
📍 Location: Online
Learn more here.
 
share your thoughts-01
twitter button-01
nps_discovery_banner_2025
 

What’s Trending: NPS Discovery Webinar Series – April 2025

 
 

📅 Date: Thursday, April 10, 2025
🕑 Time: 11:00 am to 12:30 pm ET
📍 Location: Online
Learn more here.
 
share your thoughts-01
twitter button-01
DPA_logo_SOCIAL
 

New Drugs and Markets Session 2: Addressing Myths, Misinfo, and Real Harms

 
 

📅 Date: Thursday, April 10, 2025
🕑 Time: 3:30 pm to 5:00 pm ET
📍 Location: Online

Learn more here.
 
share your thoughts-01
twitter button-01
ccorc-2025-call-for-abstracts-and-sessions-1
 

Call for submissions: Cannabis Clinical Outcomes 2025 Research Conference 

 
 

📅 Dates: May 29 - May 30, 2025
📍Location: UF Academic and Research Center at Lake Nona, Orlando, FL

Learn more here.
 
share your thoughts-01
twitter button-01
Testing the Waters 8 International Conference on Wastewater-based Epidemiology
 

Call for submissions: Testing the Waters - 8th Conference in Tacoma, WA

 
 

📅 Dates: June 2 - 4, 2025
📍 Location: University of Puget Sound, Tacoma, WA

Learn more here.
 
share your thoughts-01
twitter button-01
cpdd_rsa_logos
 

CPDD/RSA Joint Program, Session 2 Keynote speaker: Linda Cottler, The National Drug Early Warning System Networks, Initiatives and Data: How can we help?

 
 

📅 Date: Friday, June 20, 2025
📍 Location: New Orleans
Learn more here.
 
share your thoughts-01
twitter button-01
 

Help Support Our Work!
 
screenshot-2024-08-30-013133
 

You can share the NDEWS Weekly Briefing with friends, colleagues, and others who would benefit from information on recent and relevant news, articles, and data related to novel drug trends in the U.S. and globally by clicking here.
 
screenshot-2024-08-30-020640
NDEWS Submission Form Graphic (6)
 

Get in Touch with NDEWS

Share your research, news, and events through our submission form.
Share your comments on our newsletter through our feedback form.
For more information on NDEWS' efforts, visit our website.
Follow NDEWS on Twitter/X: @NDEWSnews
If you miss or want to learn more about NDEWS Original Content, you can find our archived content on the NDEWS website:
     • NDEWS Hotspot Alerts using substance-related EMS data
     • NDEWS Rapid Street Reporting (RSR) survey data reports
     • NDEWS Web Monitoring Team Reddit Alerts
     • NDEWS Sentinel Site Reports
     • Previous issues of the NDEWS Weekly Briefings
 
email_footer-2-2
 

The Weekly Briefing is a newsletter published each week by the National Drug Early Warning System (NDEWS) Coordinating Center, which is funded by the National Institute on Drug Abuse (U01DA051126) to the University of Florida (MPI: Cottler (contact), Co-Is: Goldberger, Nixon, Striley), New York University (MPI: Palamar), and Florida Atlantic University (Co-I: Barenholtz). Any item may be reproduced provided the source is acknowledged.
 
 
Copyright © 2025 National Drug Early Warning System (NDEWS), All rights reserved.